GLP-1 (glucagon-like peptide-1) stimulates insulin in response to elevated blood glucose, reduces glucagon output, slows gastric emptying, and signals fullness to the brain
While high-dose, continuous Rapamycin has been tied to infections, lipid abnormalities, and glucose elevation, evidence suggests that a carefully calibrated, low-dose, and potentially cyclical protocol may capture the drugs benefitssuch as enhanced autophagy and improved cellular resiliencewithout the full extent of its drawbacks
Diabetes Ther 14(12):21592172 Meier JJ (2021) Efficacy of semaglutide in a subcutaneous and an oral formulation
Preclinical and mechanistic studies have suggested potential interactions between GLP-1 signalling and bone metabolism
[ii] Fosphenytoin causes numerous side effects
As imagens so meramente ilustrativas